Insider Selling: Alphatec Holdings, Inc. (NASDAQ:ATEC) CEO Sells 6,687 Shares of Stock

Alphatec Holdings, Inc. (NASDAQ:ATEC) CEO Patrick Miles sold 6,687 shares of the business’s stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $12.00, for a total transaction of $80,244.00. Following the completion of the sale, the chief executive officer now owns 5,501,715 shares in the company, valued at approximately $66,020,580. This trade represents a 0.12 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

Alphatec Stock Up 2.5 %

ATEC traded up $0.29 on Thursday, hitting $11.67. 1,276,798 shares of the company were exchanged, compared to its average volume of 1,852,914. The firm has a 50-day moving average price of $9.80 and a two-hundred day moving average price of $8.08. The company has a current ratio of 2.32, a quick ratio of 1.15 and a debt-to-equity ratio of 30.21. Alphatec Holdings, Inc. has a twelve month low of $4.88 and a twelve month high of $17.34. The company has a market cap of $1.66 billion, a price-to-earnings ratio of -9.12 and a beta of 1.41.

Hedge Funds Weigh In On Alphatec

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Atria Investments Inc lifted its stake in Alphatec by 8.0% in the third quarter. Atria Investments Inc now owns 19,609 shares of the medical technology company’s stock worth $109,000 after acquiring an additional 1,460 shares during the last quarter. Entropy Technologies LP raised its holdings in shares of Alphatec by 14.9% in the 3rd quarter. Entropy Technologies LP now owns 21,623 shares of the medical technology company’s stock valued at $120,000 after purchasing an additional 2,800 shares in the last quarter. R Squared Ltd purchased a new stake in shares of Alphatec during the 4th quarter worth $29,000. Wrapmanager Inc. grew its stake in shares of Alphatec by 9.5% during the third quarter. Wrapmanager Inc. now owns 38,399 shares of the medical technology company’s stock worth $213,000 after purchasing an additional 3,325 shares in the last quarter. Finally, Nisa Investment Advisors LLC increased its holdings in Alphatec by 973.3% in the fourth quarter. Nisa Investment Advisors LLC now owns 4,669 shares of the medical technology company’s stock valued at $43,000 after buying an additional 4,234 shares during the last quarter. 66.35% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on ATEC shares. Barclays lifted their price target on shares of Alphatec from $20.00 to $21.00 and gave the company an “overweight” rating in a research report on Wednesday. HC Wainwright reiterated a “buy” rating and issued a $20.00 target price on shares of Alphatec in a report on Tuesday, January 14th. Finally, Needham & Company LLC raised their price target on Alphatec from $13.00 to $16.00 and gave the stock a “buy” rating in a research report on Monday, January 13th. One equities research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat, Alphatec has an average rating of “Moderate Buy” and a consensus price target of $17.56.

Alphatec Company Profile

Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.